Warfarin-associated intraventricular hemorrhage

Alexander Zubkov, Daniel O. Claassen, Alejandro Rabinstein

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

Objective: In this study, we have reviewed our experience with anticoagulation-associated intraventricular hemorrhage (IVH). Our goal was to determine if IVH is also an independent prognosticator of fatal outcome in patients with anticoagulation-associated intracerebral hemorrhage (ICH). Methods: This study is a retrospective analysis of medical records and computed tomographic imaging. Eighty-eight patients with warfarin-associated ICH were analysed, including eight patients with predominant IVH. Results: There was a very low rate of hemorrhage extension in patients with predominant IVH. Despite that, those patients had 50% 30 day mortality. Overall patients with ICH had 45% 30 day mortality. Ventricular extension raised mortality in ICH patients to 75%, while the absence of ventricular extension carried only 23% 30 day mortality. IVH was significantly associated with 30 day mortality (p<0.001). Panventricular extension was uniformly fatal in patients with ICH and carried 75% 30 day mortality in patients with predominant IVH. On a multivariate logistic regression model including age, ICH volume and IVH, ICH volume (p<0.001) and IVH (p=0.003) remained independently associated with early mortality. Conclusion: Extension of anticoagulation-associated ICH into ventricular system caused a high mortality, especially in patients with panventricular involvement. IVH is an independent predictor of early death in these patients. In our experience, the majority of IVH do not expand over time and poor outcome appears to be related to the magnitude of the initial insult.

Original languageEnglish (US)
Pages (from-to)661-663
Number of pages3
JournalNeurological Research
Volume29
Issue number7
DOIs
StatePublished - Oct 1 2007

Fingerprint

Warfarin
Cerebral Hemorrhage
Hemorrhage
Mortality
Logistic Models
Fatal Outcome
Medical Records

Keywords

  • Anticoagulation-induced hemorrhage
  • Intraventricular hemorrhage
  • Mortality
  • Warfarin

ASJC Scopus subject areas

  • Neurology
  • Clinical Neurology

Cite this

Warfarin-associated intraventricular hemorrhage. / Zubkov, Alexander; Claassen, Daniel O.; Rabinstein, Alejandro.

In: Neurological Research, Vol. 29, No. 7, 01.10.2007, p. 661-663.

Research output: Contribution to journalArticle

Zubkov, Alexander ; Claassen, Daniel O. ; Rabinstein, Alejandro. / Warfarin-associated intraventricular hemorrhage. In: Neurological Research. 2007 ; Vol. 29, No. 7. pp. 661-663.
@article{317fdfcf91d14dc49e639c39e6df4272,
title = "Warfarin-associated intraventricular hemorrhage",
abstract = "Objective: In this study, we have reviewed our experience with anticoagulation-associated intraventricular hemorrhage (IVH). Our goal was to determine if IVH is also an independent prognosticator of fatal outcome in patients with anticoagulation-associated intracerebral hemorrhage (ICH). Methods: This study is a retrospective analysis of medical records and computed tomographic imaging. Eighty-eight patients with warfarin-associated ICH were analysed, including eight patients with predominant IVH. Results: There was a very low rate of hemorrhage extension in patients with predominant IVH. Despite that, those patients had 50{\%} 30 day mortality. Overall patients with ICH had 45{\%} 30 day mortality. Ventricular extension raised mortality in ICH patients to 75{\%}, while the absence of ventricular extension carried only 23{\%} 30 day mortality. IVH was significantly associated with 30 day mortality (p<0.001). Panventricular extension was uniformly fatal in patients with ICH and carried 75{\%} 30 day mortality in patients with predominant IVH. On a multivariate logistic regression model including age, ICH volume and IVH, ICH volume (p<0.001) and IVH (p=0.003) remained independently associated with early mortality. Conclusion: Extension of anticoagulation-associated ICH into ventricular system caused a high mortality, especially in patients with panventricular involvement. IVH is an independent predictor of early death in these patients. In our experience, the majority of IVH do not expand over time and poor outcome appears to be related to the magnitude of the initial insult.",
keywords = "Anticoagulation-induced hemorrhage, Intraventricular hemorrhage, Mortality, Warfarin",
author = "Alexander Zubkov and Claassen, {Daniel O.} and Alejandro Rabinstein",
year = "2007",
month = "10",
day = "1",
doi = "10.1179/016164107X247227",
language = "English (US)",
volume = "29",
pages = "661--663",
journal = "Neurological Research",
issn = "0161-6412",
publisher = "Maney Publishing",
number = "7",

}

TY - JOUR

T1 - Warfarin-associated intraventricular hemorrhage

AU - Zubkov, Alexander

AU - Claassen, Daniel O.

AU - Rabinstein, Alejandro

PY - 2007/10/1

Y1 - 2007/10/1

N2 - Objective: In this study, we have reviewed our experience with anticoagulation-associated intraventricular hemorrhage (IVH). Our goal was to determine if IVH is also an independent prognosticator of fatal outcome in patients with anticoagulation-associated intracerebral hemorrhage (ICH). Methods: This study is a retrospective analysis of medical records and computed tomographic imaging. Eighty-eight patients with warfarin-associated ICH were analysed, including eight patients with predominant IVH. Results: There was a very low rate of hemorrhage extension in patients with predominant IVH. Despite that, those patients had 50% 30 day mortality. Overall patients with ICH had 45% 30 day mortality. Ventricular extension raised mortality in ICH patients to 75%, while the absence of ventricular extension carried only 23% 30 day mortality. IVH was significantly associated with 30 day mortality (p<0.001). Panventricular extension was uniformly fatal in patients with ICH and carried 75% 30 day mortality in patients with predominant IVH. On a multivariate logistic regression model including age, ICH volume and IVH, ICH volume (p<0.001) and IVH (p=0.003) remained independently associated with early mortality. Conclusion: Extension of anticoagulation-associated ICH into ventricular system caused a high mortality, especially in patients with panventricular involvement. IVH is an independent predictor of early death in these patients. In our experience, the majority of IVH do not expand over time and poor outcome appears to be related to the magnitude of the initial insult.

AB - Objective: In this study, we have reviewed our experience with anticoagulation-associated intraventricular hemorrhage (IVH). Our goal was to determine if IVH is also an independent prognosticator of fatal outcome in patients with anticoagulation-associated intracerebral hemorrhage (ICH). Methods: This study is a retrospective analysis of medical records and computed tomographic imaging. Eighty-eight patients with warfarin-associated ICH were analysed, including eight patients with predominant IVH. Results: There was a very low rate of hemorrhage extension in patients with predominant IVH. Despite that, those patients had 50% 30 day mortality. Overall patients with ICH had 45% 30 day mortality. Ventricular extension raised mortality in ICH patients to 75%, while the absence of ventricular extension carried only 23% 30 day mortality. IVH was significantly associated with 30 day mortality (p<0.001). Panventricular extension was uniformly fatal in patients with ICH and carried 75% 30 day mortality in patients with predominant IVH. On a multivariate logistic regression model including age, ICH volume and IVH, ICH volume (p<0.001) and IVH (p=0.003) remained independently associated with early mortality. Conclusion: Extension of anticoagulation-associated ICH into ventricular system caused a high mortality, especially in patients with panventricular involvement. IVH is an independent predictor of early death in these patients. In our experience, the majority of IVH do not expand over time and poor outcome appears to be related to the magnitude of the initial insult.

KW - Anticoagulation-induced hemorrhage

KW - Intraventricular hemorrhage

KW - Mortality

KW - Warfarin

UR - http://www.scopus.com/inward/record.url?scp=36048995377&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=36048995377&partnerID=8YFLogxK

U2 - 10.1179/016164107X247227

DO - 10.1179/016164107X247227

M3 - Article

VL - 29

SP - 661

EP - 663

JO - Neurological Research

JF - Neurological Research

SN - 0161-6412

IS - 7

ER -